a morgentaler - Search Results

Year	Number of Results
1955	1
1964	1
1970	1
1972	1
1973	2
1974	2
1975	8
1978	1
1979	2
1985	3
1986	2
1987	1
1988	9
1989	13
1990	7
1991	6
1992	4
1993	3
1994	3
1995	7
1996	5
1997	8
1998	6
1999	2
2000	1
2001	1
2002	2
2003	5
2004	4
2005	5
2006	12
2007	12
2008	9
2009	12
2010	8
2011	10
2012	5
2013	9
2014	21
2015	17
2016	9
2017	13
2018	8
2019	11
2020	6
2021	6
2022	2

1

Editorial Comment.

Morgentaler A. Morgentaler A. J Urol. 2022 May;207(5):1028. doi: 10.1097/JU.0000000000002384.01. Epub 2022 Jan 20. J Urol. 2022. PMID: 35045725 No abstract available.

2

How the rise of testosterone therapy in men was inspired by lizard research with David Crews.

Morgentaler A. Morgentaler A. J Exp Zool A Ecol Integr Physiol. 2022 Jan;337(1):103-106. doi: 10.1002/jez.2553. Epub 2021 Dec 8. J Exp Zool A Ecol Integr Physiol. 2022. PMID: 34878221

3

Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men.

Lunenfeld B, Mskhalaya G, Zitzmann M, Corona G, Arver S, Kalinchenko S, Tishova Y, Morgentaler A. Lunenfeld B, et al. Aging Male. 2021 Dec;24(1):119-138. doi: 10.1080/13685538.2021.1962840. Aging Male. 2021. PMID: 34396893

4

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. Parish SJ, et al. J Sex Med. 2021 May;18(5):849-867. doi: 10.1016/j.jsxm.2020.10.009. Epub 2021 Apr 1. J Sex Med. 2021. PMID: 33814355 Free article. Review.

5

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. Parish SJ, et al. J Womens Health (Larchmt). 2021 Apr;30(4):474-491. doi: 10.1089/jwh.2021.29037. Epub 2021 Apr 1. J Womens Health (Larchmt). 2021. PMID: 33797277 Free PMC article.

6

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. Parish SJ, et al. Climacteric. 2021 Dec;24(6):533-550. doi: 10.1080/13697137.2021.1891773. Epub 2021 Apr 1. Climacteric. 2021. PMID: 33792440

7

Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A.

Grober ED, Krakowsky Y, Khera M, Holmes DT, Lee JC, Grantmyre JE, Patel P, Bebb RA, Fitzpatrick R, Campbell JD, Carrier S, Morgentaler A. Grober ED, et al. Can Urol Assoc J. 2021 May;15(5):E234-E243. doi: 10.5489/cuaj.7252. Can Urol Assoc J. 2021. PMID: 33661092 Free PMC article. No abstract available.

8

Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.

Morgentaler A, Traish AM. Morgentaler A, et al. Investig Clin Urol. 2020 Jul;61(4):452-454. doi: 10.4111/icu.2020.61.4.452. Epub 2020 Jun 29. Investig Clin Urol. 2020. PMID: 32666003 Free PMC article. No abstract available.

9

Successful treatment of Post-orgasmic illness syndrome with human chorionic gonadotropin.

Bolanos J, Morgentaler A. Bolanos J, et al. Urol Case Rep. 2019 Nov 22;29:101078. doi: 10.1016/j.eucr.2019.101078. eCollection 2020 Mar. Urol Case Rep. 2019. PMID: 31832334 Free PMC article.

10

A Critique of the AUA Guidelines on Testosterone Deficiency.

Morgentaler A, Traish AM, Khera M. Morgentaler A, et al. J Sex Med. 2020 Apr;17(4):561-564. doi: 10.1016/j.jsxm.2019.10.019. Epub 2019 Dec 4. J Sex Med. 2020. PMID: 31812687 No abstract available.

11

Absent Diurnal Variation in Serum Testosterone in Young Men with Testosterone Deficiency.

Shlykova N, Davidson E, Krakowsky Y, Bolanos J, Traish A, Morgentaler A. Shlykova N, et al. J Urol. 2020 Apr;203(4):817-823. doi: 10.1097/JU.0000000000000630. Epub 2019 Oct 31. J Urol. 2020. PMID: 31670607

12

Cardiovascular and Cerebrovascular Safety of Testosterone Therapy.

Traish AM, Hackett G, Miner M, Morgentaler A. Traish AM, et al. Am J Med. 2019 Oct;132(10):e748. doi: 10.1016/j.amjmed.2019.04.042. Epub 2019 Oct 21. Am J Med. 2019. PMID: 31648787 No abstract available.

13

Safety of testosterone therapy in men with prostate cancer.

Morgentaler A, Caliber M. Morgentaler A, et al. Expert Opin Drug Saf. 2019 Nov;18(11):1065-1076. doi: 10.1080/14740338.2019.1666103. Epub 2019 Sep 18. Expert Opin Drug Saf. 2019. PMID: 31495240 Review.

14

Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.

Morgentaler A, Traish A, Hackett G, Jones TH, Ramasamy R. Morgentaler A, et al. Sex Med Rev. 2019 Oct;7(4):636-649. doi: 10.1016/j.sxmr.2019.06.003. Epub 2019 Jul 24. Sex Med Rev. 2019. PMID: 31351915 Review.

CONCLUSIONS: Treatment of TD offers multiple benefits for sexual symptoms as well as for general health, without compelling evidence for increased risk of prostate cancer or cardiovascular events. Morgentaler A, Traish A, Hackett G, et al. Diagnosis and Treatment of Testos …

CONCLUSIONS: Treatment of TD offers multiple benefits for sexual symptoms as well as for general health, without compelling evidence for inc …

15

The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).

Althof S, Osterloh IH, Muirhead GJ, George K, Girard N; PEDRIX Multi-Centre Study Group. Althof S, et al. J Sex Med. 2019 Aug;16(8):1188-1198. doi: 10.1016/j.jsxm.2019.05.015. J Sex Med. 2019. PMID: 31351660 Clinical Trial.

16

Association of low testosterone with changes in non-cardiovascular biomarkers in adult men.

Samoszuk M, Morgentaler A, de Groot M, van Solinge W, Li Y, Adair F, Hoefer I, Haitjema S. Samoszuk M, et al. Int J Impot Res. 2020 Mar;32(2):167-175. doi: 10.1038/s41443-019-0112-4. Epub 2019 Jan 22. Int J Impot Res. 2020. PMID: 30670838 Free PMC article.

17

Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence.

Traish A, Bolanos J, Nair S, Saad F, Morgentaler A. Traish A, et al. J Clin Med. 2018 Dec 14;7(12):549. doi: 10.3390/jcm7120549. J Clin Med. 2018. PMID: 30558178 Free PMC article. Review.

18

Nerve growth factor as a new treatment for testosterone deficiency?

Morgentaler A. Morgentaler A. EBioMedicine. 2018 Oct;36:10-11. doi: 10.1016/j.ebiom.2018.09.017. Epub 2018 Sep 22. EBioMedicine. 2018. PMID: 30249544 Free PMC article. No abstract available.

19

Current Diagnostic Criteria for Testosterone Deficiency Are Inadequate.

Morgentaler A. Morgentaler A. Eur Urol Focus. 2018 Apr;4(3):348-350. doi: 10.1016/j.euf.2018.08.014. Epub 2018 Sep 14. Eur Urol Focus. 2018. PMID: 30224264

20

Testosterone therapy and medical hysteria.

Morgentaler A. Morgentaler A. Nat Rev Urol. 2018 Nov;15(11):659-660. doi: 10.1038/s41585-018-0081-2. Nat Rev Urol. 2018. PMID: 30166594 No abstract available.

21

Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results.

Traish AM, Krakowsky Y, Doros G, Morgentaler A. Traish AM, et al. Sex Med Rev. 2019 Jan;7(1):95-114. doi: 10.1016/j.sxmr.2018.06.002. Epub 2018 Aug 8. Sex Med Rev. 2019. PMID: 30098986

22

The History of Testosterone and the Evolution of its Therapeutic Potential.

Morgentaler A, Traish A. Morgentaler A, et al. Sex Med Rev. 2020 Apr;8(2):286-296. doi: 10.1016/j.sxmr.2018.03.002. Epub 2018 Apr 13. Sex Med Rev. 2020. PMID: 29661690 Review.

CONCLUSIONS: If the past has any lessons for the future, it is likely that research will continue to demonstrate health benefits of testosterone therapy, while it remains one of the most controversial topics in medicine. Morgentaler A, Traish A. The History of Testosterone …

CONCLUSIONS: If the past has any lessons for the future, it is likely that research will continue to demonstrate health benefits of testoste …

23

The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.

Miner M, Morgentaler A, Khera M, Traish AM. Miner M, et al. Clin Endocrinol (Oxf). 2018 Jul;89(1):3-10. doi: 10.1111/cen.13589. Epub 2018 Apr 14. Clin Endocrinol (Oxf). 2018. PMID: 29486065 Review.

24

Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men.

Lopez DS, Qiu X, Advani S, Tsilidis KK, Khera M, Kim J, Morgentaler A, Wang R, Canfield S. Lopez DS, et al. Clin Endocrinol (Oxf). 2018 Jan;88(1):58-65. doi: 10.1111/cen.13501. Epub 2017 Nov 20. Clin Endocrinol (Oxf). 2018. PMID: 29067698 Free article.

25

Testosterone Therapy in a Man with Intermediate-risk Prostate Cancer: Pro.

Morgentaler A. Morgentaler A. Eur Urol Focus. 2017 Oct;3(4-5):316-318. doi: 10.1016/j.euf.2017.09.007. Epub 2017 Oct 5. Eur Urol Focus. 2017. PMID: 28988938

26

Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels.

Morgentaler A, Polzer P, Althof S, Bolyakov A, Donatucci C, Ni X, Patel AB, Basaria S. Morgentaler A, et al. J Sex Med. 2017 Sep;14(9):1116-1124. doi: 10.1016/j.jsxm.2017.06.013. Epub 2017 Aug 12. J Sex Med. 2017. PMID: 28807505 Clinical Trial.

CONCLUSION: IELT and MELT were longer in men with DE, and there was no association of ejaculation times with serum testosterone levels in this study population. Morgentaler A, Polzer P, Althof S, et al. Delayed Ejaculation and Associated Complaints: Relationship to Ejacula …

CONCLUSION: IELT and MELT were longer in men with DE, and there was no association of ejaculation times with serum testosterone levels in th …

27

Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth.

Krakowsky Y, Morgentaler A. Krakowsky Y, et al. Eur Urol Focus. 2019 Jan;5(1):81-89. doi: 10.1016/j.euf.2017.06.008. Epub 2017 Jul 1. Eur Urol Focus. 2019. PMID: 28753828 Review.

28

Serum Concentrations of Sex Hormone-binding Globulin Vary Widely in Younger and Older Men: Clinical Data from a Men's Health Practice.

Krakowsky Y, Conners W, Morgentaler A. Krakowsky Y, et al. Eur Urol Focus. 2019 Mar;5(2):273-279. doi: 10.1016/j.euf.2017.05.007. Epub 2017 Jun 3. Eur Urol Focus. 2019. PMID: 28753796

29

Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States.

Krakowsky Y, Conners W, Davidson E, Rawji A, Morgentaler A. Krakowsky Y, et al. Urology. 2017 Nov;109:27-31. doi: 10.1016/j.urology.2017.07.007. Epub 2017 Jul 19. Urology. 2017. PMID: 28735014

30

Reply to Eugenio Ventimiglia, Paolo Capogrosso, Walter Cazzaniga, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Giovanni Corona, Giulia Rastrelli, Abraham Morgentaler, Alessandra Sforza, Edoardo Mannucci, Mario Maggi. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol 2017;72:1000-11.

Rastrelli G, Corona G, Mannucci E, Maggi M. Rastrelli G, et al. Eur Urol. 2017 Dec;72(6):e162-e163. doi: 10.1016/j.eururo.2017.05.051. Epub 2017 Jun 21. Eur Urol. 2017. PMID: 28647215 No abstract available.

31

Re: Giovanni Corona, Giulia Rastrelli, Abraham Morgentaler, Alessandra Sforza, Edoardo Mannucci, Mario Maggi. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol 2017;72:1000-11.

Ventimiglia E, Capogrosso P, Cazzaniga W, Montorsi F, Salonia A. Ventimiglia E, et al. Eur Urol. 2017 Dec;72(6):e160-e161. doi: 10.1016/j.eururo.2017.05.050. Epub 2017 Jun 7. Eur Urol. 2017. PMID: 28601351 No abstract available.

32

Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.

Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Corona G, et al. Eur Urol. 2017 Dec;72(6):1000-1011. doi: 10.1016/j.eururo.2017.03.032. Epub 2017 Apr 20. Eur Urol. 2017. PMID: 28434676 Review.

33

Andrology: Testosterone reference ranges and diagnosis of testosterone deficiency.

Morgentaler A. Morgentaler A. Nat Rev Urol. 2017 May;14(5):263-264. doi: 10.1038/nrurol.2017.35. Epub 2017 Mar 7. Nat Rev Urol. 2017. PMID: 28266512 No abstract available.

34

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Salonia A, et al. J Sex Med. 2017 Mar;14(3):297-315. doi: 10.1016/j.jsxm.2016.11.324. J Sex Med. 2017. PMID: 28262100

35

Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Salonia A, et al. J Sex Med. 2017 Mar;14(3):285-296. doi: 10.1016/j.jsxm.2016.11.325. J Sex Med. 2017. PMID: 28262099

36

Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy.

Traish AM, Vance JC, Morgentaler A. Traish AM, et al. EMBO Rep. 2017 Jan;18(1):11-17. doi: 10.15252/embr.201643642. Epub 2016 Dec 5. EMBO Rep. 2017. PMID: 27920032 Free PMC article.

37

Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A. Khera M, et al. J Sex Med. 2016 Dec;13(12):1787-1804. doi: 10.1016/j.jsxm.2016.10.009. J Sex Med. 2016. PMID: 27914560 Review.

38

Male and Female Sexual Dysfunction in a Rapidly Changing Cultural Environment: Addressing Gender Equality versus Equivalence in the Bedroom.

Brandon M, Morgentaler A. Brandon M, et al. Sex Med Rev. 2016 Apr;4(2):96-102. doi: 10.1016/j.sxmr.2015.12.002. Epub 2016 Jan 11. Sex Med Rev. 2016. PMID: 27872026 Review.

39

Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro.

Morgentaler A. Morgentaler A. J Urol. 2016 Oct;196(4):985-8. doi: 10.1016/j.juro.2016.07.075. Epub 2016 Jul 20. J Urol. 2016. PMID: 27449261 Review. No abstract available.

40

Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions.

Morgentaler A, Zitzmann M, Traish AM, Fox AW, Jones TH, Maggi M, Arver S, Aversa A, Chan JC, Dobs AS, Hackett GI, Hellstrom WJ, Lim P, Lunenfeld B, Mskhalaya G, Schulman CC, Torres LO. Morgentaler A, et al. Mayo Clin Proc. 2016 Jul;91(7):881-96. doi: 10.1016/j.mayocp.2016.04.007. Epub 2016 Jun 21. Mayo Clin Proc. 2016. PMID: 27313122

41

Testosterone Therapy and Prostate Cancer.

Davidson E, Morgentaler A. Davidson E, et al. Urol Clin North Am. 2016 May;43(2):209-16. doi: 10.1016/j.ucl.2016.01.007. Urol Clin North Am. 2016. PMID: 27132578 Review.

42

Testosterone Therapy in Men With Prostate Cancer.

Kaplan AL, Hu JC, Morgentaler A, Mulhall JP, Schulman CC, Montorsi F. Kaplan AL, et al. Eur Urol. 2016 May;69(5):894-903. doi: 10.1016/j.eururo.2015.12.005. Epub 2015 Dec 21. Eur Urol. 2016. PMID: 26719015 Free PMC article. Review.

43

Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.

Morgentaler A. Morgentaler A. Urology. 2016 Mar;89:27-32. doi: 10.1016/j.urology.2015.11.034. Epub 2015 Dec 9. Urology. 2016. PMID: 26683750 Review.

44

International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic.

Morgentaler A, Zitzmann M, Traish AM, Fox A. Morgentaler A, et al. Aging Male. 2015;18(4):205-6. doi: 10.3109/13685538.2015.1106469. Epub 2015 Nov 20. Aging Male. 2015. PMID: 26586191

45

Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study.

Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, Patel AB, Basaria S. Paduch DA, et al. J Sex Med. 2015 Dec;12(12):2276-86. doi: 10.1111/jsm.13027. Epub 2015 Oct 29. J Sex Med. 2015. PMID: 26511106

46

The practical management of testosterone deficiency in men.

Aversa A, Morgentaler A. Aversa A, et al. Nat Rev Urol. 2015 Nov;12(11):641-50. doi: 10.1038/nrurol.2015.238. Epub 2015 Oct 13. Nat Rev Urol. 2015. PMID: 26458755 Review.

47

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results.

Kacker R, Hult M, San Francisco IF, Conners WP, Rojas PA, Dewolf WC, Morgentaler A. Kacker R, et al. Asian J Androl. 2016 Jan-Feb;18(1):16-20. doi: 10.4103/1008-682X.160270. Asian J Androl. 2016. PMID: 26306850 Free PMC article.

48

Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.

Baillargeon J, Urban RJ, Morgentaler A, Glueck CJ, Baillargeon G, Sharma G, Kuo YF. Baillargeon J, et al. Mayo Clin Proc. 2015 Aug;90(8):1038-45. doi: 10.1016/j.mayocp.2015.05.012. Epub 2015 Jul 20. Mayo Clin Proc. 2015. PMID: 26205547

49

The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men.

Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, Bivalacqua TJ, Burnett AL, Buvat J, El Meliegy A, Hellstrom WJ, Jannini EA, Maggi M, McCullough A, Torres LO, Zitzmann M. Dean JD, et al. J Sex Med. 2015 Aug;12(8):1660-86. doi: 10.1111/jsm.12952. J Sex Med. 2015. PMID: 26081680 Review.

50

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.

Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M. Pastuszak AW, et al. J Urol. 2015 Nov;194(5):1271-6. doi: 10.1016/j.juro.2015.05.084. Epub 2015 May 27. J Urol. 2015. PMID: 26025500

51

Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.

Baillargeon J, Urban RJ, Kuo YF, Holmes HM, Raji MA, Morgentaler A, Howrey BT, Lin YL, Ottenbacher KJ. Baillargeon J, et al. Public Health Rep. 2015 Mar-Apr;130(2):143-52. doi: 10.1177/003335491513000207. Public Health Rep. 2015. PMID: 25729103 Free PMC article.

52

Testosterone and cardiovascular disease--the controversy and the facts.

Morgentaler A, Feibus A, Baum N. Morgentaler A, et al. Postgrad Med. 2015 Mar;127(2):159-65. doi: 10.1080/00325481.2015.996111. Postgrad Med. 2015. PMID: 25708023 Review.

53

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y, Morgentaler A. Lunenfeld B, et al. Aging Male. 2015 Mar;18(1):5-15. doi: 10.3109/13685538.2015.1004049. Epub 2015 Feb 6. Aging Male. 2015. PMID: 25657080 Free PMC article.

54

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.

Morgentaler A 3rd, Conners WP. Morgentaler A 3rd, et al. Asian J Androl. 2015 Mar-Apr;17(2):206-11. doi: 10.4103/1008-682X.148067. Asian J Androl. 2015. PMID: 25652633 Free PMC article. Review.

55

Testosterone therapy and cardiovascular risk: advances and controversies.

Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Morgentaler A, et al. Mayo Clin Proc. 2015 Feb;90(2):224-51. doi: 10.1016/j.mayocp.2014.10.011. Mayo Clin Proc. 2015. PMID: 25636998 Review.

56

RE: Testosterone treatment is a potent tumor promoter for the rat prostate.

Traish AM, Morgentaler A, Khera M. Traish AM, et al. Endocrinology. 2015 Jan;156(1):L1-2. doi: 10.1210/en.2014-1843. Endocrinology. 2015. PMID: 25526553 No abstract available.

57

Testosterone deficiency and cardiovascular mortality.

Morgentaler A. Morgentaler A. Asian J Androl. 2015 Jan-Feb;17(1):26-31. doi: 10.4103/1008-682X.143248. Asian J Androl. 2015. PMID: 25432501 Free PMC article. Review.

58

Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.

Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, Jones TH. Zarotsky V, et al. Andrology. 2014 Nov;2(6):819-34. doi: 10.1111/andr.274. Epub 2014 Oct 1. Andrology. 2014. PMID: 25269643 Free article. Review.

59

Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.

Morgentaler A, Benesh JA, Denes BS, Kan-Dobrosky N, Harb D, Miller MG. Morgentaler A, et al. J Sex Med. 2014 Nov;11(11):2818-25. doi: 10.1111/jsm.12657. Epub 2014 Aug 18. J Sex Med. 2014. PMID: 25131184 Clinical Trial.

60

Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.

Balbontin FG, Moreno SA, Bley E, Chacon R, Silva A, Morgentaler A. Balbontin FG, et al. BJU Int. 2014 Jul;114(1):125-30. doi: 10.1111/bju.12668. BJU Int. 2014. PMID: 25101359

61

Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial.

Morgentaler A, McGettigan J, Xiang Q, Danoff TM, Gould EM. Morgentaler A, et al. Int J Impot Res. 2015 Mar-Apr;27(2):41-5. doi: 10.1038/ijir.2014.28. Epub 2014 Jul 24. Int J Impot Res. 2015. PMID: 25056809 Clinical Trial.

62

New concepts regarding testosterone and prostate cancer: a breath of fresh air.

Morgentaler A. Morgentaler A. Oncology (Williston Park). 2014 May;28(5):404-5. Oncology (Williston Park). 2014. PMID: 25004654 Free article. No abstract available.

63

Will I have a heart attack or stroke if I take testosterone therapy?

Morgentaler A. Morgentaler A. J Sex Med. 2014 Jun;11(6):1601-2. doi: 10.1111/jsm.12580. J Sex Med. 2014. PMID: 24905250 No abstract available.

64

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance.

San Francisco IF, Rojas PA, DeWolf WC, Morgentaler A. San Francisco IF, et al. BJU Int. 2014 Aug;114(2):229-35. doi: 10.1111/bju.12682. Epub 2014 May 4. BJU Int. 2014. PMID: 24898919

65

Medical hypothesis: loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction.

Kacker R, Morgentaler A, Traish A. Kacker R, et al. J Sex Med. 2014 Aug;11(8):1898-902. doi: 10.1111/jsm.12574. Epub 2014 May 16. J Sex Med. 2014. PMID: 24836599 Review.

(ii) 5alpha-DHT is important to the structural/functional integrity of penile tissues and erectile physiology. Kacker R, Morgentaler A, and Traish A. Medical hypothesis: Loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy …

(ii) 5alpha-DHT is important to the structural/functional integrity of penile tissues and erectile physiology. Kacker R, Morgentaler …

66

Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23.

Khera M, Morgentaler A. Khera M, et al. Eur Urol. 2014 Aug;66(2):e33. doi: 10.1016/j.eururo.2014.04.016. Epub 2014 May 2. Eur Urol. 2014. PMID: 24836155 No abstract available.

67

Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23.

Klap J, Loughlin KR. Klap J, et al. Eur Urol. 2014 Aug;66(2):e31-2. doi: 10.1016/j.eururo.2014.04.017. Epub 2014 May 2. Eur Urol. 2014. PMID: 24830626 No abstract available.

68

Testosterone and cardiovascular risk: world's experts take unprecedented action to correct misinformation.

Morgentaler A, Lunenfeld B. Morgentaler A, et al. Aging Male. 2014 Jun;17(2):63-5. doi: 10.3109/13685538.2014.913413. Epub 2014 May 6. Aging Male. 2014. PMID: 24797617 No abstract available.

69

Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions.

Morgentaler A, Khera M, Maggi M, Zitzmann M. Morgentaler A, et al. J Sex Med. 2014 Jul;11(7):1636-45. doi: 10.1111/jsm.12546. Epub 2014 May 2. J Sex Med. 2014. PMID: 24797325

70

Testosterone, cardiovascular risk, and hormonophobia.

Morgentaler A. Morgentaler A. J Sex Med. 2014 Jun;11(6):1362-6. doi: 10.1111/jsm.12556. Epub 2014 May 2. J Sex Med. 2014. PMID: 24787518

71

Does testosterone increase the risk of a cardiovascular event?

Seftel AD, Morgentaler A. Seftel AD, et al. J Urol. 2014 Jul;192(1):13-5. doi: 10.1016/j.juro.2014.04.021. Epub 2014 Apr 16. J Urol. 2014. PMID: 24746882 No abstract available.

72

Deaths and cardiovascular events in men receiving testosterone.

Morgentaler A, Traish A, Kacker R. Morgentaler A, et al. JAMA. 2014 Mar 5;311(9):961-2. doi: 10.1001/jama.2014.392. JAMA. 2014. PMID: 24595783 No abstract available.

73

Death by testosterone? We think not!

Traish AM, Guay AT, Morgentaler A. Traish AM, et al. J Sex Med. 2014 Mar;11(3):624-9. doi: 10.1111/jsm.12464. J Sex Med. 2014. PMID: 24589170 No abstract available.

74

Andrology: Testosterone and cardiovascular risk--deciphering the statistics.

Morgentaler A, Kacker R. Morgentaler A, et al. Nat Rev Urol. 2014 Mar;11(3):131-2. doi: 10.1038/nrurol.2014.24. Epub 2014 Feb 18. Nat Rev Urol. 2014. PMID: 24535586 No abstract available.

75

Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.

Kacker R, Harisaran V, Given L, Miner M, Rittmaster R, Morgentaler A. Kacker R, et al. Andrologia. 2015 Mar;47(2):148-52. doi: 10.1111/and.12237. Epub 2014 Feb 6. Andrologia. 2015. PMID: 24499051 Clinical Trial.

76

Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens.

Gooren L, Morgentaler A. Gooren L, et al. Andrologia. 2014 Dec;46(10):1156-60. doi: 10.1111/and.12208. Epub 2013 Dec 12. Andrologia. 2014. PMID: 24329588

77

Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility.

Kacker R, Conners W, Zade J, Morgentaler A. Kacker R, et al. J Urol. 2014 Apr;191(4):1072-6. doi: 10.1016/j.juro.2013.10.070. Epub 2013 Oct 23. J Urol. 2014. PMID: 24161998

78

Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population.

Kacker R, Hornstein A, Morgentaler A. Kacker R, et al. Aging Male. 2013 Dec;16(4):164-8. doi: 10.3109/13685538.2013.835800. Epub 2013 Oct 3. Aging Male. 2013. PMID: 24090209

79

Henry Morgentaler: model for the UK?

Argent V. Argent V. J Fam Plann Reprod Health Care. 2013 Oct;39(4):247-9. doi: 10.1136/jfprhc-2013-100691. J Fam Plann Reprod Health Care. 2013. PMID: 24062496 Free article. No abstract available.

80

[Patient with testosterone deficit syndrome after radical prostatectomy].

Linares Espinós E, Martínez-Salamanca JI, Morgentaler A, Moncada I, del Portillo L, Rodríguez-Izquierdo M, Areche J, Carballido J. Linares Espinós E, et al. Arch Esp Urol. 2013 Sep;66(7):663-8. Arch Esp Urol. 2013. PMID: 24047624 Review. Spanish.

81

A new era of testosterone and prostate cancer: from physiology to clinical implications.

Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. Khera M, et al. Eur Urol. 2014 Jan;65(1):115-23. doi: 10.1016/j.eururo.2013.08.015. Epub 2013 Aug 16. Eur Urol. 2014. PMID: 24011426 Review.

82

The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

Conners WP 3rd, Morgentaler A. Conners WP 3rd, et al. Curr Urol Rep. 2013 Dec;14(6):557-64. doi: 10.1007/s11934-013-0370-5. Curr Urol Rep. 2013. PMID: 23999611 Review.

83

Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.

Traish AM, Morgentaler A. Traish AM, et al. J Steroid Biochem Mol Biol. 2013 Nov;138:462. doi: 10.1016/j.jsbmb.2013.06.013. Epub 2013 Jul 9. J Steroid Biochem Mol Biol. 2013. PMID: 23851167 No abstract available.

84

Testosterone therapy in men with prostate cancer: scientific and ethical considerations.

Morgentaler A. Morgentaler A. J Urol. 2013 Jan;189(1 Suppl):S26-33. doi: 10.1016/j.juro.2012.11.028. J Urol. 2013. PMID: 23234627 Review.

85

Goodbye androgen hypothesis, hello saturation model.

Morgentaler A. Morgentaler A. Eur Urol. 2012 Nov;62(5):765-7. doi: 10.1016/j.eururo.2012.06.027. Epub 2012 Jun 16. Eur Urol. 2012. PMID: 22728116 No abstract available.

86

Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.

Morgentaler A. Morgentaler A. BJU Int. 2012 Dec;110(11 Pt B):E547. doi: 10.1111/j.1464-410X.2012.11243.x. Epub 2012 May 15. BJU Int. 2012. PMID: 22583384 No abstract available.

87

Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency.

Kacker R, Traish AM, Morgentaler A. Kacker R, et al. J Sex Med. 2012 Jun;9(6):1681-96. doi: 10.1111/j.1743-6109.2012.02726.x. Epub 2012 Apr 18. J Sex Med. 2012. PMID: 22512993 Review.

88

A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion.

McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. McCullough AR, et al. J Sex Med. 2012 Feb;9(2):594-601. doi: 10.1111/j.1743-6109.2011.02570.x. Epub 2012 Jan 12. J Sex Med. 2012. PMID: 22240203

89

Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy.

Di Sante S, Conners WP, Morgentaler A. Di Sante S, et al. J Sex Med. 2012 Feb;9(2):585-93. doi: 10.1111/j.1743-6109.2011.02557.x. Epub 2011 Dec 6. J Sex Med. 2012. PMID: 22145684

90

Re: Testosterone therapy in men with untreated prostate cancer. A. Morgentaler, L. I. Lipshultz, R. Bennett, M. Sweeney, D. Avila, Jr. and M. Khera. J Urol 2011; 185: 1256-1261.

Friedman AE. Friedman AE. J Urol. 2011 Oct;186(4):1559; author reply 1560. doi: 10.1016/j.juro.2011.05.064. J Urol. 2011. PMID: 21907684 No abstract available.

91

Outcomes with the "V" implantation technique vs. standard technique for testosterone pellet therapy.

Conners W, Flinn K, Morgentaler A. Conners W, et al. J Sex Med. 2011 Dec;8(12):3465-70. doi: 10.1111/j.1743-6109.2011.02441.x. Epub 2011 Aug 24. J Sex Med. 2011. PMID: 21883944

92

Testosterone deficiency.

Traish AM, Miner MM, Morgentaler A, Zitzmann M. Traish AM, et al. Am J Med. 2011 Jul;124(7):578-87. doi: 10.1016/j.amjmed.2010.12.027. Am J Med. 2011. PMID: 21683825 Review.

93

Testosterone and prostate cancer: what are the risks for middle-aged men?

Morgentaler A. Morgentaler A. Urol Clin North Am. 2011 May;38(2):119-24. doi: 10.1016/j.ucl.2011.02.002. Epub 2011 Apr 13. Urol Clin North Am. 2011. PMID: 21621078 Review.

94

Is testosterone a friend or a foe of the prostate?

Jannini EA, Gravina GL, Morgentaler A, Morales A, Incrocci L, Hellstrom WJ. Jannini EA, et al. J Sex Med. 2011 Apr;8(4):946-55. doi: 10.1111/j.1743-6109.2011.02233.x. J Sex Med. 2011. PMID: 21457469 Review.

95

Words of wisdom. Re: Adverse events associated with testosterone administration.

Morgentaler A. Morgentaler A. Eur Urol. 2011 Mar;59(3):465. doi: 10.1016/j.eururo.2010.12.027. Eur Urol. 2011. PMID: 21414881 No abstract available.

96

Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer.

Morgentaler A. Morgentaler A. Cancer. 2011 Sep 1;117(17):3885-8. doi: 10.1002/cncr.25975. Epub 2011 Mar 1. Cancer. 2011. PMID: 21365620 Free article. No abstract available.

97

Testosterone therapy in men with untreated prostate cancer.

Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D Jr, Khera M. Morgentaler A, et al. J Urol. 2011 Apr;185(4):1256-60. doi: 10.1016/j.juro.2010.11.084. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334649

98

The NERI Hypogonadism Screener: psychometric validation in male patients and controls.

Rosen RC, Araujo AB, Connor MK, Gerstenberger EP, Morgentaler A, Seftel AD, Miner MM, Shabsigh R. Rosen RC, et al. Clin Endocrinol (Oxf). 2011 Feb;74(2):248-56. doi: 10.1111/j.1365-2265.2010.03925.x. Clin Endocrinol (Oxf). 2011. PMID: 21114509

99

Should hypogonadal men with prostate cancer receive testosterone?

Morgentaler A, Morales A. Morgentaler A, et al. J Urol. 2010 Oct;184(4):1257-60. doi: 10.1016/j.juro.2010.07.010. Epub 2010 Aug 17. J Urol. 2010. PMID: 20723918 No abstract available.

100

Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges.

Glina S, Rivero MA, Morales A, Morgentaler A. Glina S, et al. J Sex Med. 2010 Feb;7(2 Pt 1):640-4. doi: 10.1111/j.1743-6109.2009.01680.x. J Sex Med. 2010. PMID: 20492413 No abstract available.

101

Endocrine aspects of male sexual dysfunctions.

Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A, Zitzmann M. Buvat J, et al. J Sex Med. 2010 Apr;7(4 Pt 2):1627-56. doi: 10.1111/j.1743-6109.2010.01780.x. J Sex Med. 2010. PMID: 20388162

102

Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.

Morgentaler A, Rhoden EL, Guay A, Traish A. Morgentaler A, et al. BJU Int. 2010 Mar;105(6):884-5; author reply 885-6. doi: 10.1111/j.1464-410X.2010.09277_1.x. BJU Int. 2010. PMID: 20353537 No abstract available.

103

Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.

Gacci M, Corona G, Apolone G, Lanciotti M, Tosi N, Giancane S, Masieri L, Serni S, Maggi M, Carini M. Gacci M, et al. Prostate Cancer Prostatic Dis. 2010 Jun;13(2):168-72. doi: 10.1038/pcan.2010.4. Epub 2010 Mar 9. Prostate Cancer Prostatic Dis. 2010. PMID: 20212520 Free PMC article.

The correlation between preoperative PSA and T in men with low T is in agreement with the 'saturation' model proposed by Morgentaler. The correlation between basal T and preoperative erectile function and urinary continence underlines the importance of assessing T before R …

The correlation between preoperative PSA and T in men with low T is in agreement with the 'saturation' model proposed by Morgentaler. …

104

Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice.

Rhoden EL, Morgentaler A. Rhoden EL, et al. J Sex Med. 2010 Jan;7(1 Pt 1):277-83. doi: 10.1111/j.1743-6109.2009.01544.x. J Sex Med. 2010. PMID: 20104673

105

Classics of urology: a half century history of the most frequently cited articles (1955-2009).

Heldwein FL, Rhoden EL, Morgentaler A. Heldwein FL, et al. Urology. 2010 Jun;75(6):1261-8. doi: 10.1016/j.urology.2009.09.043. Epub 2009 Dec 4. Urology. 2010. PMID: 19962736 Review.

106

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.

Traish AM, Morgentaler A. Traish AM, et al. Br J Cancer. 2009 Dec 15;101(12):1949-56. doi: 10.1038/sj.bjc.6605376. Epub 2009 Nov 3. Br J Cancer. 2009. PMID: 19888222 Free PMC article. Review.

107

Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls.

Rosen RC, Araujo AB, Connor MK, Elstad EA, McGraw SA, Guay AT, Morgentaler A, Miner MM. Rosen RC, et al. Aging Male. 2009 Jun-Sep;12(2-3):77-85. doi: 10.1080/13685530903184043. Aging Male. 2009. PMID: 19811219

108

Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population.

Moreno SA, Shyam A, Morgentaler A. Moreno SA, et al. J Sex Med. 2010 May;7(5):1948-53. doi: 10.1111/j.1743-6109.2009.01473.x. Epub 2009 Sep 1. J Sex Med. 2010. PMID: 19732301

109

Rapidly shifting concepts regarding androgens and prostate cancer.

Morgentaler A. Morgentaler A. ScientificWorldJournal. 2009 Jul 27;9:685-90. doi: 10.1100/tsw.2009.80. ScientificWorldJournal. 2009. PMID: 19649507 Free PMC article. Review.

110

Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship.

Moreno SA, Morgentaler A. Moreno SA, et al. J Sex Med. 2009 Jun;6(6):1729-1735. doi: 10.1111/j.1743-6109.2009.01250.x. Epub 2009 Mar 30. J Sex Med. 2009. PMID: 19473459

111

Testosterone and prostate cancer: revisiting old paradigms.

Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C. Isbarn H, et al. Eur Urol. 2009 Jul;56(1):48-56. doi: 10.1016/j.eururo.2009.03.088. Epub 2009 Apr 8. Eur Urol. 2009. PMID: 19375844 Review.

112

Re: Abraham Morgentaler, Abdulmaged M. Traish. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009;55:310-21.

Friedman AE. Friedman AE. Eur Urol. 2009 Jul;56(1):e4; author reply e5. doi: 10.1016/j.eururo.2009.03.068. Epub 2009 Apr 1. Eur Urol. 2009. PMID: 19349108 No abstract available.

113

Two years of testosterone therapy associated with decline in prostate-specific antigen in a man with untreated prostate cancer.

Morgentaler A. Morgentaler A. J Sex Med. 2009 Feb;6(2):574-7. doi: 10.1111/j.1743-6109.2008.01066.x. J Sex Med. 2009. PMID: 19215619

114

Testosterone therapy in men with prostate cancer: scientific and ethical considerations.

Morgentaler A. Morgentaler A. J Urol. 2009 Mar;181(3):972-9. doi: 10.1016/j.juro.2008.11.031. Epub 2009 Jan 16. J Urol. 2009. PMID: 19150547 Review.

115

Testosterone and prostate safety.

Morgentaler A, Schulman C. Morgentaler A, et al. Front Horm Res. 2009;37:197-203. doi: 10.1159/000176054. Front Horm Res. 2009. PMID: 19011298 Review.

116

Does testosterone therapy increase the risk of prostate cancer?

Dobs AS, Morgentaler A. Dobs AS, et al. Endocr Pract. 2008 Oct;14(7):904-11. doi: 10.4158/EP.14.7.904. Endocr Pract. 2008. PMID: 18996823 Review.

117

Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.

Morgentaler A, Dobs AS, Kaufman JM, Miner MM, Shabsigh R, Swerdloff RS, Wang C. Morgentaler A, et al. J Urol. 2008 Dec;180(6):2307-13. doi: 10.1016/j.juro.2008.08.126. Epub 2008 Oct 18. J Urol. 2008. PMID: 18930255

118

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.

Morgentaler A, Traish AM. Morgentaler A, et al. Eur Urol. 2009 Feb;55(2):310-20. doi: 10.1016/j.eururo.2008.09.024. Epub 2008 Sep 24. Eur Urol. 2009. PMID: 18838208 Review.

119

Why I do abortions: speech to the Morgentaler Symposium, Toronto, 25 January 2008.

Romalis G. Romalis G. Reprod Health Matters. 2008 May;16(31 Suppl):66-8. doi: 10.1016/S0968-8080(08)31381-0. Reprod Health Matters. 2008. PMID: 18772085 No abstract available.

120

Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer.

Morgentaler A. Morgentaler A. J Sex Med. 2008 Aug;5(8):1834-40. doi: 10.1111/j.1743-6109.2008.00889.x. Epub 2008 Jun 10. J Sex Med. 2008. PMID: 18547385

121

Re: effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Morgentaler A. Morgentaler A. Eur Urol. 2008 May;53(5):1084. doi: 10.1016/j.eururo.2008.02.008. Eur Urol. 2008. PMID: 18485319 No abstract available.

122

Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.

Morgentaler A. Morgentaler A. Int J Impot Res. 2008 May-Jun;20(3):331; author reply 332. doi: 10.1038/ijir.2008.5. Int J Impot Res. 2008. PMID: 18475269 No abstract available.

123

The effect of aging on spermatogenesis and pregnancy outcomes.

Lazarou S, Morgentaler A. Lazarou S, et al. Urol Clin North Am. 2008 May;35(2):331-9, xi. doi: 10.1016/j.ucl.2008.01.006. Urol Clin North Am. 2008. PMID: 18423252 Review.

124

The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men.

Rhoden EL, Riedner CE, Morgentaler A. Rhoden EL, et al. J Urol. 2008 May;179(5):1741-4. doi: 10.1016/j.juro.2008.01.045. Epub 2008 Mar 17. J Urol. 2008. PMID: 18343420

125

Testosterone replacement therapy and prostate cancer.

Morgentaler A. Morgentaler A. Urol Clin North Am. 2007 Nov;34(4):555-63, vii. doi: 10.1016/j.ucl.2007.08.002. Urol Clin North Am. 2007. PMID: 17983895

126

Far from home? A pilot study tracking women's journeys to a Canadian abortion clinic.

Sethna C, Doull M. Sethna C, et al. J Obstet Gynaecol Can. 2007 Aug;29(8):640-7. doi: 10.1016/s1701-2163(16)32560-9. J Obstet Gynaecol Can. 2007. PMID: 17714617

The geographical distance to an abortion provider is acknowledged as a major barrier to access. This pilot study tracks women's journeys to the Toronto Morgentaler Clinic for abortion services. METHODS: A questionnaire was developed specifically for this study and was admi …

The geographical distance to an abortion provider is acknowledged as a major barrier to access. This pilot study tracks women's journeys to …

127

The association of time of day and serum testosterone concentration in a large screening population.

Crawford ED, Barqawi AB, O'Donnell C, Morgentaler A. Crawford ED, et al. BJU Int. 2007 Sep;100(3):509-13. doi: 10.1111/j.1464-410X.2007.07022.x. Epub 2007 Jun 6. BJU Int. 2007. PMID: 17555474

128

Penile rehabilitation should become the norm for radical prostatectomy patients.

Mulhall JP, Morgentaler A. Mulhall JP, et al. J Sex Med. 2007 May;4(3):538-543. doi: 10.1111/j.1743-6109.2007.00486.x. J Sex Med. 2007. PMID: 17498093

129

Cultural biases and scientific squabbles: the challenges to acceptance of testosterone therapy as a mainstream medical treatment.

Morgentaler A. Morgentaler A. Aging Male. 2007 Mar;10(1):1-2. doi: 10.1080/13685530701283906. Aging Male. 2007. PMID: 17454976 No abstract available.

130

Re: The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.

Morgentaler A. Morgentaler A. J Urol. 2007 May;177(5):1954. doi: 10.1016/j.juro.2007.01.042. J Urol. 2007. PMID: 17437855 No abstract available.

131

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship.

Morgentaler A. Morgentaler A. Eur Urol. 2007 Sep;52(3):623-5. doi: 10.1016/j.eururo.2007.04.005. Epub 2007 Apr 9. Eur Urol. 2007. PMID: 17433531 No abstract available.

132

Re: Masashi Yano, Takashi Imamoto, Hiroyoshi Suzuki et Al. The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening. Eur urol 2007;51:375-80.

Morgentaler A. Morgentaler A. Eur Urol. 2007 Jul;52(1):292; author reply 293-4. doi: 10.1016/j.eururo.2007.03.045. Epub 2007 Mar 28. Eur Urol. 2007. PMID: 17400361 No abstract available.

133

New concepts regarding the relationship of testosterone and prostate cancer.

Morgentaler A. Morgentaler A. Future Oncol. 2007 Apr;3(2):123-6. doi: 10.2217/14796694.3.2.123. Future Oncol. 2007. PMID: 17381410 No abstract available.

134

Commentary: Guideline for male testosterone therapy: a clinician's perspective.

Morgentaler A. Morgentaler A. J Clin Endocrinol Metab. 2007 Feb;92(2):416-7. doi: 10.1210/jc.2006-2629. J Clin Endocrinol Metab. 2007. PMID: 17284642 Review. No abstract available.

135

Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.

Morgentaler A, Rhoden EL. Morgentaler A, et al. Urology. 2006 Dec;68(6):1263-7. doi: 10.1016/j.urology.2006.08.1058. Urology. 2006. PMID: 17169647

136

Outcomes and satisfaction rates for the redesigned 2-piece penile prosthesis.

Lux M, Reyes-Vallejo L, Morgentaler A, Levine LA. Lux M, et al. J Urol. 2007 Jan;177(1):262-6. doi: 10.1016/j.juro.2006.08.094. J Urol. 2007. PMID: 17162061

137

Wide variability in laboratory reference values for serum testosterone.

Lazarou S, Reyes-Vallejo L, Morgentaler A. Lazarou S, et al. J Sex Med. 2006 Nov;3(6):1085-1089. doi: 10.1111/j.1743-6109.2006.00334.x. J Sex Med. 2006. PMID: 17100942

138

Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.

Reyes-Vallejo L, Lazarou S, Morgentaler A. Reyes-Vallejo L, et al. J Sex Med. 2007 Nov;4(6):1757-62. doi: 10.1111/j.1743-6109.2006.00381.x. Epub 2006 Nov 6. J Sex Med. 2007. PMID: 17087806

139

Technical advances in penile prostheses.

Lazarou S, Reyes-Vallejo L, Morgentaler A. Lazarou S, et al. J Long Term Eff Med Implants. 2006;16(3):235-47. doi: 10.1615/jlongtermeffmedimplants.v16.i3.40. J Long Term Eff Med Implants. 2006. PMID: 17073566

140

Testosterone therapy for men at risk for or with history of prostate cancer.

Morgentaler A. Morgentaler A. Curr Treat Options Oncol. 2006 Sep;7(5):363-9. doi: 10.1007/s11864-006-0004-y. Curr Treat Options Oncol. 2006. PMID: 16904053 Review.

141

Testosterone and prostate cancer: an historical perspective on a modern myth.

Morgentaler A. Morgentaler A. Eur Urol. 2006 Nov;50(5):935-9. doi: 10.1016/j.eururo.2006.06.034. Epub 2006 Jul 27. Eur Urol. 2006. PMID: 16875775 Review.

142

Phleboliths in varicoceles presenting as spermatic cord mass.

Lazarou S, Reyes-Vallejo L, Morgentaler A. Lazarou S, et al. Fertil Steril. 2006 Jul;86(1):219.e21-2. doi: 10.1016/j.fertnstert.2005.12.043. Fertil Steril. 2006. PMID: 16818036

143

Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.

Morgentaler A, Barada J, Niederberger C, Donatucci C, Garcia CS, Natanegara F, Ahuja S, Wong DG. Morgentaler A, et al. J Sex Med. 2006 May;3(3):492-503. doi: 10.1111/j.1743-6109.2006.00209.x. J Sex Med. 2006. PMID: 16681475 Clinical Trial.

144

Testosterone replacement therapy and prostate risks: where's the beef?

Morgentaler A. Morgentaler A. Can J Urol. 2006 Feb;13 Suppl 1:40-3. Can J Urol. 2006. PMID: 16526980 Review.

145

Re: Prostate cancer in men using testosterone supplementation. F. D. Gaylis, D. W. Lin, J. M. Ignatoff, C. L. Amling, R. F. Tutrone and D. J. Cosgrove.

Morgentaler A, Rhoden EL, Barqawi AB, Crawford ED. Morgentaler A, et al. J Urol. 2006 Apr;175(4):1572; author reply 1573-4. doi: 10.1016/S0022-5347(05)00691-9. J Urol. 2006. PMID: 16516047 No abstract available.

146

Y chromosome microdeletions and male infertility: who should be tested and why?

Reyes-Vallejo L, Lazarou S, Morgentaler A. Reyes-Vallejo L, et al. BJU Int. 2006 Mar;97(3):441-3. doi: 10.1111/j.1464-410X.2006.06057.x. BJU Int. 2006. PMID: 16469004 No abstract available.

147

Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.

Lazarou S, Morgentaler A. Lazarou S, et al. Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z. Curr Urol Rep. 2005. PMID: 16238923 Review.

148

Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.

Rhoden EL, Morgentaler A. Rhoden EL, et al. Int J Impot Res. 2006 Mar-Apr;18(2):201-5. doi: 10.1038/sj.ijir.3901394. Int J Impot Res. 2006. PMID: 16177827

149

Quality of life following simultaneous placement of penile prosthesis with radical prostatectomy.

Ramsawh HJ, Morgentaler A, Covino N, Barlow DH, DeWolf WC. Ramsawh HJ, et al. J Urol. 2005 Oct;174(4 Pt 1):1395-8. doi: 10.1097/01.ju.0000173939.86858.d6. J Urol. 2005. PMID: 16145445

150

Testosterone replacement therapy and the risk of prostate cancer: a perspective view.

Barqawi AB, Crawford ED. Barqawi AB, et al. Int J Impot Res. 2005 Sep-Oct;17(5):462-3. doi: 10.1038/sj.ijir.3901323. Int J Impot Res. 2005. PMID: 15889127

The Food and Drug Administration appears to support this cautionary stance. Counter arguments by Rhoden and Morgentaler in the New England Journal of Medicine suggest that T-replacement therapy in aging men may be safe under controlled settings. ...

The Food and Drug Administration appears to support this cautionary stance. Counter arguments by Rhoden and Morgentaler in the New En …

151

Part 3: surgical palliation of advanced illness: what's new, what's helpful.

Cady B, Barker F, Easson A, Aboulafia AJ, Ferson PF, Miner T, Morgentaler A. Cady B, et al. J Am Coll Surg. 2005 Mar;200(3):457-66. doi: 10.1016/j.jamcollsurg.2004.10.029. J Am Coll Surg. 2005. PMID: 15737858 No abstract available.

152

Part 2: Surgical palliation of advanced illness: what's new, what's helpful.

Cady B, Miner T, Morgentaler A. Cady B, et al. J Am Coll Surg. 2005 Feb;200(2):281-90. doi: 10.1016/j.jamcollsurg.2004.11.015. J Am Coll Surg. 2005. PMID: 15664106 No abstract available.

153

A 66-year-old man with sexual dysfunction.

Morgentaler A. Morgentaler A. JAMA. 2004 Jun 23;291(24):2994-3003. doi: 10.1001/jama.291.24.2994. JAMA. 2004. PMID: 15213212 No abstract available.

154

Romanow and Kirby on the public/private divide in healthcare: demystifying the debate.

Chodos H, MacLeod JJ. Chodos H, et al. Healthc Pap. 2004;4(4):10-25. doi: 10.12927/hcpap..16849. Healthc Pap. 2004. PMID: 15201525

As well, we examine examples of private delivery of health services, including the Morgentaler clinics, that point to the importance of retaining the space for experimentation with forms of delivery that currently exists within the Canadian healthcare system....

As well, we examine examples of private delivery of health services, including the Morgentaler clinics, that point to the importance …

155

Erectile dysfunction.

Rhoden EL, Morgentaler A. Rhoden EL, et al. J Long Term Eff Med Implants. 2003;13(6):519-28. doi: 10.1615/jlongtermeffmedimplants.v13.i6.80. J Long Term Eff Med Implants. 2003. PMID: 15056069 Review.

156

Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.

Rhoden EL, Morgentaler A. Rhoden EL, et al. Int J Impot Res. 2004 Feb;16(1):95-7. doi: 10.1038/sj.ijir.3901154. Int J Impot Res. 2004. PMID: 14963480

157

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden EL, Morgentaler A. Rhoden EL, et al. N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251. N Engl J Med. 2004. PMID: 14749457 Review. No abstract available.

158

Heat-induced testicular apoptosis occurs independently of hormonal depletion.

Yin Y, Stahl BC, DeWolf WC, Morgentaler A. Yin Y, et al. Apoptosis. 1998 Sep;3(4):281-7. doi: 10.1023/a:1009665309915. Apoptosis. 1998. PMID: 14646492

159

Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.

Rhoden EL, Morgentaler A. Rhoden EL, et al. J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413

160

Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats.

Rhoden EL, Gobbi D, Rhoden CR, Menti E, Roehe AN, Hartmann A, Morgentaler A. Rhoden EL, et al. J Urol. 2003 Nov;170(5):2101-3. doi: 10.1097/01.ju.0000091827.97826.57. J Urol. 2003. PMID: 14532863

161

The value of pituitary magnetic resonance imaging in men with hypogonadism.

Rhoden EL, Estrada C, Levine L, Morgentaler A. Rhoden EL, et al. J Urol. 2003 Sep;170(3):795-8. doi: 10.1097/01.ju.0000082960.84075.54. J Urol. 2003. PMID: 12913700

162

Morgentaler's call for secular-only hospitals earns tepid response.

Gagnon L. Gagnon L. CMAJ. 2003 Feb 4;168(3):331. CMAJ. 2003. PMID: 12566353 Free PMC article. No abstract available.

163

NB, Morgentaler head to court over abortion payments.

Thorne T. Thorne T. CMAJ. 2002 Nov 26;167(11):1277. CMAJ. 2002. PMID: 12451091 Free PMC article. No abstract available.

164

Roe v. Wade. Canada's example.

Morgentaler H. Morgentaler H. Conscience. 1998 Winter;18(4):31. Conscience. 1998. PMID: 12178886

In this commentary, Dr. Henry Morgentaler notes that the US Supreme Court's Roe vs. Wade decision inspired him to openly challenge the Canadian abortion law by publicly announcing in 1973 that he had performed more than 5000 abortions at his Montreal clinic. ...The eight …

In this commentary, Dr. Henry Morgentaler notes that the US Supreme Court's Roe vs. Wade decision inspired him to openly challenge th …

165

P53 and Fas are sequential mechanisms of testicular germ cell apoptosis.

Yin Y, Stahl BC, DeWolf WC, Morgentaler A. Yin Y, et al. J Androl. 2002 Jan-Feb;23(1):64-70. doi: 10.1002/jand.2002.23.1.64. J Androl. 2002. PMID: 11780924 Free article.

166

Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study.

Levine LA, Estrada CR, Morgentaler A. Levine LA, et al. J Urol. 2001 Sep;166(3):932-7. J Urol. 2001. PMID: 11490249

167

Is low serum free testosterone a marker for high grade prostate cancer?

Hoffman MA, DeWolf WC, Morgentaler A. Hoffman MA, et al. J Urol. 2000 Mar;163(3):824-7. J Urol. 2000. PMID: 10687985

168

Male impotence.

Morgentaler A. Morgentaler A. Lancet. 1999 Nov 13;354(9191):1713-8. doi: 10.1016/S0140-6736(99)06586-1. Lancet. 1999. PMID: 10568586 Review.

169

Testis and temperature: an historical, clinical, and research perspective.

Morgentaler A, Stahl BC, Yin Y. Morgentaler A, et al. J Androl. 1999 Mar-Apr;20(2):189-95. J Androl. 1999. PMID: 10232653 Free article. Review. No abstract available.

170

p53-mediated germ cell quality control in spermatogenesis.

Yin Y, Stahl BC, DeWolf WC, Morgentaler A. Yin Y, et al. Dev Biol. 1998 Dec 1;204(1):165-71. doi: 10.1006/dbio.1998.9074. Dev Biol. 1998. PMID: 9851850 Free article.

171

Motile organisms in the epididymis?

Morgentaler A. Morgentaler A. Hum Reprod. 1998 Aug;13(8):2335. doi: 10.1093/oxfordjournals.humrep.a019720. Hum Reprod. 1998. PMID: 9756322 No abstract available.

172

Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice.

Yin Y, DeWolf WC, Morgentaler A. Yin Y, et al. Biol Reprod. 1998 Feb;58(2):492-6. doi: 10.1095/biolreprod58.2.492. Biol Reprod. 1998. PMID: 9475406

173

Partial duplication of the vas deferens.

Khoudary KP, Morgentaler A. Khoudary KP, et al. J Urol. 1998 Mar;159(3):988-9. J Urol. 1998. PMID: 9474205 No abstract available.

174

Causality and association--more than just different shades of gray.

Morgentaler A. Morgentaler A. Fertil Steril. 1997 Oct;68(4):745. Fertil Steril. 1997. PMID: 9341625 No abstract available.

175

Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients.

Khoudary KP, DeWolf WC, Bruning CO 3rd, Morgentaler A. Khoudary KP, et al. Urology. 1997 Sep;50(3):395-9. doi: 10.1016/S0090-4295(97)00280-X. Urology. 1997. PMID: 9301704

176

p53 is associated with the nuclear envelope in mouse testis.

Yin Y, DeWolf WC, Morgentaler A. Yin Y, et al. Biochem Biophys Res Commun. 1997 Jun 27;235(3):689-94. doi: 10.1006/bbrc.1997.6867. Biochem Biophys Res Commun. 1997. PMID: 9207221

177

Temperature-mediated germ cell loss in the testis is associated with altered expression of the cell-cycle regulator p53.

Socher SA, Yin Y, Dewolf WC, Morgentaler A. Socher SA, et al. J Urol. 1997 May;157(5):1986-9. J Urol. 1997. PMID: 9112577

178

Heat stress causes testicular germ cell apoptosis in adult mice.

Yin Y, Hawkins KL, DeWolf WC, Morgentaler A. Yin Y, et al. J Androl. 1997 Mar-Apr;18(2):159-65. J Androl. 1997. PMID: 9154510 Free article.

179

Congenital anomalies of the vas deferens, epididymis, and seminal vesicles.

Vohra S, Morgentaler A. Vohra S, et al. Urology. 1997 Mar;49(3):313-21. doi: 10.1016/S0090-4295(96)00433-5. Urology. 1997. PMID: 9123691 Review. No abstract available.

180

Access to abortion in Ontario: from Morgentaler 1988 to the Savings and Restructuring Act.

Farid C. Farid C. Health Law J. 1997;5:119-45. Health Law J. 1997. PMID: 10569896 No abstract available.

181

Occult prostate cancer in men with low serum testosterone levels.

Morgentaler A, Bruning CO 3rd, DeWolf WC. Morgentaler A, et al. JAMA. 1996 Dec 18;276(23):1904-6. JAMA. 1996. PMID: 8968017

182

Design considerations in penile prostheses: the American Medical Systems product line.

Khoudary KP, Morgentaler A. Khoudary KP, et al. J Long Term Eff Med Implants. 1997;7(1):55-64. J Long Term Eff Med Implants. 1997. PMID: 10168541

183

Violent words, violent deeds.

Morgentaler H. Morgentaler H. Conscience. 1996 Autumn;17(3):7-9. Conscience. 1996. PMID: 12178872

In this letter, Morgentaler recounts his personal experience of the violence and threats issued by anti-abortion activists and notes that he is a survivor of two Nazi death camps. ...As a Holocaust survivor, Morgentaler also notes his belief that comparing abortion …

In this letter, Morgentaler recounts his personal experience of the violence and threats issued by anti-abortion activists and notes …

184

Ureteral pseudodiverticulosis: the case for the retrograde urogram.

Socher SA, Dewolf WC, Morgentaler A. Socher SA, et al. Urology. 1996 Jun;47(6):924-7. doi: 10.1016/S0090-4295(96)00055-6. Urology. 1996. PMID: 8677594 Review.

185

Management of impending sterility.

Maranchie J, Morgentaler A. Maranchie J, et al. Lancet. 1996 May 11;347(9011):1344. doi: 10.1016/s0140-6736(96)91000-4. Lancet. 1996. PMID: 8622551 No abstract available.

186

Penile mass caused by the newly described organism Mycobacterium celatum.

Dahl DM, Klein D, Morgentaler A. Dahl DM, et al. Urology. 1996 Feb;47(2):266-8. doi: 10.1016/S0090-4295(99)80433-6. Urology. 1996. PMID: 8607251 Review.

187

Sperm morphology and in vitro fertilization outcome: a direct comparison of World Health Organization and strict criteria methodologies.

Morgentaler A, Fung MY, Harris DH, Powers RD, Alper MM. Morgentaler A, et al. Fertil Steril. 1995 Dec;64(6):1177-82. doi: 10.1016/s0015-0282(16)57981-3. Fertil Steril. 1995. PMID: 7589673

188

Detached ciliary tufts in the epididymis: a lesson in applied anatomy.

Comiter CV, Bruning CO 3rd, Morgentaler A. Comiter CV, et al. Urology. 1995 Nov;46(5):740-2. doi: 10.1016/S0090-4295(99)80315-X. Urology. 1995. PMID: 7495135

189

Re: Unilateral unitary inflatable penile prosthesis to correct impaired tumescence and severe penile deformity resulting from traumatic rupture of 1 corpus cavernosum.

Bruning CO 3rd, Morgentaler A. Bruning CO 3rd, et al. J Urol. 1995 Sep;154(3):1145. doi: 10.1016/s0022-5347(01)67010-1. J Urol. 1995. PMID: 7637072 No abstract available.

190

Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen.

Brown LF, Yeo KT, Berse B, Morgentaler A, Dvorak HF, Rosen S. Brown LF, et al. J Urol. 1995 Aug;154(2 Pt 1):576-9. doi: 10.1097/00005392-199508000-00073. J Urol. 1995. PMID: 7609140

191

Spontaneous corporeal herniation of the penis: a new abnormality of the tunica albuginea?

Watson DL, Morgentaler A. Watson DL, et al. J Urol. 1995 Mar;153(3 Pt 1):737-40. doi: 10.1097/00005392-199503000-00055. J Urol. 1995. PMID: 7861525

192

Temperature-dependent expression of a 95 kD protein in rat testis.

Rubenstein SC, Green LS, Schopperle WM, DeWolf WC, Morgentaler A. Rubenstein SC, et al. Andrologia. 1995 Mar-Apr;27(2):107-13. doi: 10.1111/j.1439-0272.1995.tb01079.x. Andrologia. 1995. PMID: 7598227

193

Experience with the penile prosthesis and artificial urinary sphincter.

Bruning CO 3rd, Breslin DS, Morgentaler A, Staskin DR. Bruning CO 3rd, et al. J Long Term Eff Med Implants. 1995;5(1):27-45. J Long Term Eff Med Implants. 1995. PMID: 10163507 Review.

194

Two generations of abortion providers.

Joffe C. Joffe C. Am J Ethics Med. 1994 Fall;3(1):7-10. Am J Ethics Med. 1994. PMID: 11652829 No abstract available.

195

The effect of testicular nongerm cell tumors on local spermatogenesis.

Ho GT, Gardner H, Mostofi K, DeWolf WC, Loughlin KR, Morgentaler A. Ho GT, et al. Fertil Steril. 1994 Jul;62(1):162-6. doi: 10.1016/s0015-0282(16)56833-2. Fertil Steril. 1994. PMID: 8005282

196

Hyponatremic encephalopathy after endometrial ablation.

Morgentaler A. Morgentaler A. JAMA. 1994 Feb 2;271(5):344; author reply 345. doi: 10.1001/jama.271.5.344a. JAMA. 1994. PMID: 8283577 No abstract available.

197

A self-expanding prostatic stent for bladder outlet obstruction in high risk patients.

Morgentaler A, DeWolf WC. Morgentaler A, et al. J Urol. 1993 Nov;150(5 Pt 2):1636-40. doi: 10.1016/s0022-5347(17)35862-7. J Urol. 1993. PMID: 7692101

198

Vasectomy and increased risk of prostate cancer.

Morgentaler A, DeWolf WC. Morgentaler A, et al. JAMA. 1993 Aug 11;270(6):705-6; author reply 708. doi: 10.1001/jama.1993.03510060051019. JAMA. 1993. PMID: 8336363 No abstract available.

199

The construction of health care and the ideology of the private in Canadian constitutional law.

Lessard H. Lessard H. Ann Health Law. 1993;2:121-59. Ann Health Law. 1993. PMID: 10139964

200

Bombing of Toronto abortion clinic raises stakes in bitter debate.

Bagley G. Bagley G. CMAJ. 1992 Nov 15;147(10):1528-33. CMAJ. 1992. PMID: 1423091 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results